{"id":3272,"date":"2020-02-12T14:28:10","date_gmt":"2020-02-12T13:28:10","guid":{"rendered":"https:\/\/www.corpfincapital.com\/?p=3272"},"modified":"2026-04-27T00:32:09","modified_gmt":"2026-04-26T22:32:09","slug":"palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas","status":"publish","type":"post","link":"https:\/\/www.corpfincapital.com\/en\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\/","title":{"rendered":"Palex M\u00e9dical, advances in the fight against cancer through new diagnostic tests."},"content":{"rendered":"

Dr. Xavier Carbonell, CEO of the company, has promoted the creation of a laboratory and oncological diagnosis division, and new diagnostic tests, more precise and reliable than existing diagnostic tests, have been added to the portfolio.
For example, OC-Sensor<\/strong> is \u201ca worldwide benchmark test for the early detection of colorectal cancer,\u201d according to Dr. Xavier Carbonell.
Another of Palex\u2019s most advanced tests is the Oncotype DX Breast Recurrence Score<\/strong>\u2122, which represents the only genomic test that predicts the benefit of chemotherapy treatment for a given group of patients with early-stage breast cancer.
In Urology, Palex Medical also has two tests that provide great added value, such as Oncotype DX\u00ae Genomic Prostate Score<\/strong>\u2122 and Bladder Eppicheck\u00ae<\/strong> or diagnosis of the bladder.<\/p>\n\n\n\n

Want to know more?<\/h3>\n\n\n\n

Palex Medical empresa de Corpfin Capital<\/a>: Precisi\u00f3n diagn\u00f3stica en la lucha contra el c\u00e1ncer \u2013 Palexmedical.com
Corpfin Capital y Palex Medical<\/a>: Luchan contra el c\u00e1ncer \u2013 Lavanguardia.com<\/p>\n\n\n\n


<\/p>\n\n\n\n\n View article\n<\/a>","protected":false},"excerpt":{"rendered":"

Palex M\u00e9dical, one of Corpfin Capital\u2019s portfolio companies, specializes in medical solutions for hospitals and health professionals, placing innovation and patient care as the main axes of its activity.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3272","post","type-post","status-publish","format-standard","hentry","category-sin-categoria"],"acf":[],"yoast_head":"\nPalex M\u00e9dical, avanza en la lucha contra el c\u00e1ncer con nuevas pruebas diagn\u00f3sticas. - Corpfin Capital<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.corpfincapital.com\/en\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Palex M\u00e9dical, avanza en la lucha contra el c\u00e1ncer con nuevas pruebas diagn\u00f3sticas. - Corpfin Capital\" \/>\n<meta property=\"og:description\" content=\"Palex M\u00e9dical, participada por Corpfin Capital, est\u00e1 especializada en soluciones m\u00e9dicas a hospitales y profesionales de la salud, situando la innovaci\u00f3n y la atenci\u00f3n al paciente como los ejes de su actividad\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.corpfincapital.com\/en\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\/\" \/>\n<meta property=\"og:site_name\" content=\"Corpfin Capital\" \/>\n<meta property=\"article:published_time\" content=\"2020-02-12T13:28:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-26T22:32:09+00:00\" \/>\n<meta name=\"author\" content=\"Brandi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brandi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.corpfincapital.com\\\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.corpfincapital.com\\\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\\\/\"},\"author\":{\"name\":\"Brandi\",\"@id\":\"https:\\\/\\\/www.corpfincapital.com\\\/#\\\/schema\\\/person\\\/c00f7bb70f73e49847fb54d233697245\"},\"headline\":\"Palex M\u00e9dical, avanza en la lucha contra el c\u00e1ncer con nuevas pruebas diagn\u00f3sticas.\",\"datePublished\":\"2020-02-12T13:28:10+00:00\",\"dateModified\":\"2026-04-26T22:32:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.corpfincapital.com\\\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\\\/\"},\"wordCount\":215,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.corpfincapital.com\\\/#organization\"},\"articleSection\":[\"Sin categor\u00eda\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.corpfincapital.com\\\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.corpfincapital.com\\\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\\\/\",\"url\":\"https:\\\/\\\/www.corpfincapital.com\\\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\\\/\",\"name\":\"Palex M\u00e9dical, avanza en la lucha contra el c\u00e1ncer con nuevas pruebas diagn\u00f3sticas. - Corpfin Capital\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.corpfincapital.com\\\/#website\"},\"datePublished\":\"2020-02-12T13:28:10+00:00\",\"dateModified\":\"2026-04-26T22:32:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.corpfincapital.com\\\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.corpfincapital.com\\\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.corpfincapital.com\\\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.corpfincapital.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Palex M\u00e9dical, avanza en la lucha contra el c\u00e1ncer con nuevas pruebas diagn\u00f3sticas.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.corpfincapital.com\\\/#website\",\"url\":\"https:\\\/\\\/www.corpfincapital.com\\\/\",\"name\":\"Corpfin Capital\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.corpfincapital.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.corpfincapital.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.corpfincapital.com\\\/#organization\",\"name\":\"Corpfin Capital\",\"url\":\"https:\\\/\\\/www.corpfincapital.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.corpfincapital.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.corpfincapital.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Corpfin-Capital_Logo.png\",\"contentUrl\":\"https:\\\/\\\/www.corpfincapital.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Corpfin-Capital_Logo.png\",\"width\":1250,\"height\":313,\"caption\":\"Corpfin Capital\"},\"image\":{\"@id\":\"https:\\\/\\\/www.corpfincapital.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.corpfincapital.com\\\/#\\\/schema\\\/person\\\/c00f7bb70f73e49847fb54d233697245\",\"name\":\"Brandi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f15feb686ed98fe242b62674d834e7fd00ef74c6f010ea03dfc09496eee15689?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f15feb686ed98fe242b62674d834e7fd00ef74c6f010ea03dfc09496eee15689?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f15feb686ed98fe242b62674d834e7fd00ef74c6f010ea03dfc09496eee15689?s=96&d=mm&r=g\",\"caption\":\"Brandi\"},\"sameAs\":[\"https:\\\/\\\/www.corpfincapital.com\"],\"url\":\"https:\\\/\\\/www.corpfincapital.com\\\/en\\\/author\\\/brandi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Palex M\u00e9dical, avanza en la lucha contra el c\u00e1ncer con nuevas pruebas diagn\u00f3sticas. - Corpfin Capital","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.corpfincapital.com\/en\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\/","og_locale":"en_GB","og_type":"article","og_title":"Palex M\u00e9dical, avanza en la lucha contra el c\u00e1ncer con nuevas pruebas diagn\u00f3sticas. - Corpfin Capital","og_description":"Palex M\u00e9dical, participada por Corpfin Capital, est\u00e1 especializada en soluciones m\u00e9dicas a hospitales y profesionales de la salud, situando la innovaci\u00f3n y la atenci\u00f3n al paciente como los ejes de su actividad","og_url":"https:\/\/www.corpfincapital.com\/en\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\/","og_site_name":"Corpfin Capital","article_published_time":"2020-02-12T13:28:10+00:00","article_modified_time":"2026-04-26T22:32:09+00:00","author":"Brandi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Brandi","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.corpfincapital.com\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\/#article","isPartOf":{"@id":"https:\/\/www.corpfincapital.com\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\/"},"author":{"name":"Brandi","@id":"https:\/\/www.corpfincapital.com\/#\/schema\/person\/c00f7bb70f73e49847fb54d233697245"},"headline":"Palex M\u00e9dical, avanza en la lucha contra el c\u00e1ncer con nuevas pruebas diagn\u00f3sticas.","datePublished":"2020-02-12T13:28:10+00:00","dateModified":"2026-04-26T22:32:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.corpfincapital.com\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\/"},"wordCount":215,"commentCount":0,"publisher":{"@id":"https:\/\/www.corpfincapital.com\/#organization"},"articleSection":["Sin categor\u00eda"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.corpfincapital.com\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.corpfincapital.com\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\/","url":"https:\/\/www.corpfincapital.com\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\/","name":"Palex M\u00e9dical, avanza en la lucha contra el c\u00e1ncer con nuevas pruebas diagn\u00f3sticas. - Corpfin Capital","isPartOf":{"@id":"https:\/\/www.corpfincapital.com\/#website"},"datePublished":"2020-02-12T13:28:10+00:00","dateModified":"2026-04-26T22:32:09+00:00","breadcrumb":{"@id":"https:\/\/www.corpfincapital.com\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.corpfincapital.com\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.corpfincapital.com\/palex-medical-avanza-en-la-lucha-contra-el-cancer-con-nuevas-pruebas-diagnosticas\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.corpfincapital.com\/"},{"@type":"ListItem","position":2,"name":"Palex M\u00e9dical, avanza en la lucha contra el c\u00e1ncer con nuevas pruebas diagn\u00f3sticas."}]},{"@type":"WebSite","@id":"https:\/\/www.corpfincapital.com\/#website","url":"https:\/\/www.corpfincapital.com\/","name":"Corpfin Capital","description":"","publisher":{"@id":"https:\/\/www.corpfincapital.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.corpfincapital.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.corpfincapital.com\/#organization","name":"Corpfin Capital","url":"https:\/\/www.corpfincapital.com\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.corpfincapital.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.corpfincapital.com\/wp-content\/uploads\/2025\/12\/Corpfin-Capital_Logo.png","contentUrl":"https:\/\/www.corpfincapital.com\/wp-content\/uploads\/2025\/12\/Corpfin-Capital_Logo.png","width":1250,"height":313,"caption":"Corpfin Capital"},"image":{"@id":"https:\/\/www.corpfincapital.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.corpfincapital.com\/#\/schema\/person\/c00f7bb70f73e49847fb54d233697245","name":"Brandi","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/f15feb686ed98fe242b62674d834e7fd00ef74c6f010ea03dfc09496eee15689?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f15feb686ed98fe242b62674d834e7fd00ef74c6f010ea03dfc09496eee15689?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f15feb686ed98fe242b62674d834e7fd00ef74c6f010ea03dfc09496eee15689?s=96&d=mm&r=g","caption":"Brandi"},"sameAs":["https:\/\/www.corpfincapital.com"],"url":"https:\/\/www.corpfincapital.com\/en\/author\/brandi\/"}]}},"_links":{"self":[{"href":"https:\/\/www.corpfincapital.com\/en\/wp-json\/wp\/v2\/posts\/3272","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.corpfincapital.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.corpfincapital.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.corpfincapital.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.corpfincapital.com\/en\/wp-json\/wp\/v2\/comments?post=3272"}],"version-history":[{"count":0,"href":"https:\/\/www.corpfincapital.com\/en\/wp-json\/wp\/v2\/posts\/3272\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.corpfincapital.com\/en\/wp-json\/wp\/v2\/media?parent=3272"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.corpfincapital.com\/en\/wp-json\/wp\/v2\/categories?post=3272"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.corpfincapital.com\/en\/wp-json\/wp\/v2\/tags?post=3272"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}